The number of people who develop and die from cancer in Greater Manchester are significantly higher than the English average. We also know that in Greater Manchester and the North West cancer is often not spotted early enough.
Our research aims to reduce the burden of common cancers with a strong inherited component. We are addressing this by developing screening strategies and biomarkers to identify cancer sooner, matching individual patients to the prevention treatment most likely to work for them and, in some cases, our work will even help to prevent conditions progressing into cancer in the first place.
Greater Manchester is home to world-leading researchers in cancer care and prevention, with particular expertise in early detection strategies in breast, gynaecological and colon cancer. We also have early strengths in prostate and lung cancer.
Our partnership comprises genetic and screening expertise from Manchester University NHS Foundation Trust and The Christie Hospital University Foundation Trust.
In 2019, Cancer Research UK (CRUK) announced a £40m investment in early detection research as part of the international ACED Alliance, with Manchester one of five centres across the UK and US.